Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Guangzhou, Guangdong, China21 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Arsenic Trioxide Combined With Chemotherapy for Relapsed SHH-Activated and/or TP53-Mutant Medulloblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, epithelial neoplasm, glioma, medulloblastoma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Not yet recruiting | Phase 2 | 2026-10-02 | NCT07856069 | |
| Long-Term Outcomes of Endoscopic-assisted vs Conventional Breast-conserving Surgery in Breast Cancer Patients After Neoadjuvant Therapy: a Randomized, Multicenter, Open Label, Non-inferiority Trial | Breast Cancer Invasive | Recruiting | Not applicable | 2026-09-30 | NCT06716073 | |
| Effect of HCQ Combined With LT4 on LBR in Euthyroid Women With URPL and TPO-Ab | Euthyroid With Thyroid Antibodies; Recurrent Pregnancy Loss | Recruiting | Not applicable | 2026-09-30 | NCT06652113 | |
| Phase II Neoadjuvant Pyrotinib Combined With Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open Label Trial | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, hormone receptor-positive breast cancer, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2026-09-16 | NCT05165225 | |
| Neoadjuvant Culmerciclib Combined With Endocrine Therapy for Hormone Receptor-Positive， Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, hormone receptor-positive breast cancer, neoplasm, skin disorder | Recruiting | Phase 2 | 2026-09-15 | NCT07796880 | |
| Regional Radiotherapy Omission in Low-Risk Node Positive Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not stated | 2026-09-01 | NCT07179744 | |
| Neoadjuvant Pyrotinib in HR-positive and HER2-low High-risk Early Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2026-08-18 | NCT06144944 | |
| BDB-001 Phase III Trial in ANCA-Associated Vasculitis | Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, immune system disorder, necrotizing vasculitis, skin disorder, skin vascular disease, vascular disorder, vasculitis | Recruiting | Phase 3 | 2026-08-13 | NCT07168161 | |
| Real-World Study on Efficacy and Influencing Factors of Immunotherapy for Pan-Cancer Lymph Node Metastases. | Lymphatic Metastasis, Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Not yet recruiting | Not stated | 2026-04-20 | NCT07540377 | |
| Noninvasive Implantation Potential vs Morphology-Based Selection in IVF Single Blastocyst Transfer | Genital Diseases, Urogenital Diseases, infertility disorder | Not yet recruiting | Not applicable | 2026-03-10 | NCT07461077 | |
| The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome | Chemically-Induced Disorders, Drug Eruptions, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, dermatitis, drug allergy, hand-foot syndrome, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2026-02-02 | NCT05165069 | |
| Development and Prospective Validation of a Pathology-Based Artificial Intelligence Model for Predicting the Time to Castration Resistance of Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Prostatic Neoplasms, Castration-Resistant, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Not yet recruiting | Not stated | 2026-01-29 | NCT07376057 | |
| Development and Prospective Validation of a Digital Pathology-based Artificial Intelligence Diagnostic Model for Pan-cancer Lymphatic Metastasis | Lymphatic Metastasis, Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cancer, neoplasm | Recruiting | Not stated | 2025-11-28 | NCT06517979 | |
| Distribution of the Homologous Recombination-related (HRR) Genesmutationsand HRD in Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not stated | 2025-10-03 | NCT05466786 | |
| RecurIndex Guided Avoidance of Regional Nodal Irradiation for Node Positive Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not applicable | 2025-09-22 | NCT04069884 | |
| A Study of Sacituzumab Govitecan Plus Toripalimab Versus Toripalimab Plus Nab-Paclitaxel in PD-L1 Positive Advanced TNBC | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Not yet recruiting | Phase 2 | 2025-09-08 | NCT07040644 | |
| An Intelligent Pressure and Temperature Control Ureteral Soft Scope System for Treating Stones With Infection. | Calculi, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Calculi, Male Urogenital Diseases, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Urinary Calculi, Urogenital Diseases, kidney disorder, nephrolithiasis, ureteral disorder, ureterolithiasis, urinary system disorder, urolithiasis | Not yet recruiting | Not applicable | 2025-03-07 | NCT06841523 | |
| A Phase Ib/II Study Confirmed Inhibition of Autophagy Synergizes Anti-tumor Effect of High Dose CDK4/6i | Inhibition of Autophagy Synergizes Anti-tumor Effect | Recruiting | Phase 1 / Phase 2 | 2024-12-03 | NCT05953350 | |
| External Mastalgia-oil Versus Oral Tamoxifen in Premenopausal Women with Severe Mastalgia | Mastodynia, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Not yet recruiting | Phase 3 | 2024-11-29 | NCT06404775 | |
| Postoperative Adjuvant Therapy of Donafenib for Hepatocellular Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Not applicable | 2024-09-03 | NCT06581315 | |
| Leflunomide for Idiopathic Pulmonary Hemosiderosis in Children | Hemosiderosis, Pulmonary, Nutritional and Metabolic Diseases, hemosiderosis, iron metabolism disease, iron poisoning, lung disorder, metabolic disease, respiratory system disorder | Recruiting | Phase 1 / Phase 2 | 2023-07-10 | NCT05937191 |